To contact us, please fill in the form and we will be happy to contact you.
OUR TEAM
SarcoMed USA is comprised of experienced biotech entrepre- neurs with strong drug development expertise, including Sarcoidosis clinical advisors. The company has initiated a human open label study using Generium’s biosimilar DNase1, in a Proof‐of‐Concept study in Kazakhstan.